Poststreptokokal Reaktif Artrit ve Akut Romatizmal Ateş: Benzerlikler, Farklılıklar, Klinik Yaklaşım ve Tedavi

Year 2014, Volume: 16 Issue: 1, 73 - 76, 01.03.2014

Müyesser Nergiz Yanmaz

Abstract

Poststreptokoksik reaktif artrit (PSRA) ve akut romatizmal ateş (ARA) geçirilmiş farengealgrup A beta hemolitik streptokok ya da Streptococcus pyogenes enfeksiyonunun ikikomplikasyonudur. ARA çok daha önceleri tanımlanmış bir poststreptokoksik komplikasyonolmasına rağmen PSRA ilk kez 1982 de tanımlanmıştır. Bu iki komplikasyonun farklı kliniktablolar mı olduğu yoksa aynı hastalığın farklı ortaya çıkış şekilleri mi olduğu halen tartışmakonusudur. Bu derlemede bu iki klinik tablonun benzerliklerini, farklılıklarını, klinik etki veönemlerini tanımlamayı amaçladık

Keywords

Streptokok infeksiyonu, komplikasyonlar, artrit

POSTSTREPTOCOCCAL REACTIVE ARTHRITIS AND ACUTE RHEUMATIC FEVER: SIMILARITIES, DIFFERENCES, CLINICAL APPROACH AND THERAPY

Abstract

Poststreptococcal reactive arthritis (PSRA) and Acute rheumatic fever (ARF) are twocomplications of preceding pharyngeal infections with a group A beta hemolytic streptococcus(GABHS) or Streptococcus pyogenes. Although ARF is much earlier known poststreptococcalcomplication, PSRA is first described in 1982. There is ongoing debate on whether these twoconditions represent distinct clinical entities or are parts at the spectrum of the same disease. Inthis review, we aim to describe both clinical presentations, and to discuss their similarities anddifferences, clinical impacts and importance

Keywords

Streptococcal infections, complications, arthritis

References

• Goldsmith DP, Long SS. Poststreptococcal disease of childhood-a changing syndrome [abstract]. Arthritis Rheum. 1982;25 Suppl 4:S18.
• Crea MA, Mortimer Jr EA. The nature of scarlatinal arthritis. Pediatrics. 1959;23(5):879–884.
• Tibazarwa KB, Volmink JA, Mayosi BM. The incidence of acute rheumatic fever in the world: a systematic review of population based studies. Heart. 2008;94:1534–1540.
• Van der Helm-van Mill AHM. Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered. Current Opinion in Rheumatology. 2010;22: 437-442.
• Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366:155–168.
• Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford). 2004;43(8):949–954.
• Barash J. Curr Infect Dis Rep. (2013) 15:263–268.
• Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart association. Guidelines for the diagnosis of rheumatic fever, Jones criteria, 1992 update [published erratum appears in JAMA. 1993;269:476]. JAMA 1992;268:2069–2073.
• Aviles RJ, Ramakrishna G, Mohr DN, Michet CJ Jr. Poststreptococcal reactive arthritis in adults: a case series. Mayo Clin Proc. 2000;75:144–147.
• Gutierrez-Urena S, Molina J, Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Poststreptococcal reactive arthritis, clinical course, and outcome in 6 adult patients. J Rheumatol. 1995;22:1710–1713.
• De Cunto CL, Giannini EH, Fink CW, Brewer EJ, Person DA.Prognosis of children with poststreptococcal reactive arthritis. Pediatr Infect Dis J. 1988;7(10):683–686.
• Ayoub EM, Ahmed S. Update on complications of group A streptococcal infections. Curr Probl Pediatr. 1997;27(3):90– 101.
• Moorthy LN, Gaur S, Peterson MG, Landa YF, Tandon M, Lehman TJ. Poststreptococcal reactive arthritis in children: a retrospective study. Clin Pediatr. 2009;48(2):174–182.
• Tutar E, Atalay S, Yılmaz E, Uçar T, Kocak G, Imamoglu A. Rheumatol Int. 2002; 22(2):80-83.
• Van Bemmel JM, Delgado V, Holman ER, Allaart CF, Huizinga TW, Bax JJ, et al. No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum. 2009;60(4):987–993.
• Simonini G, Taddio A, Cimaz R. No evidence yet to change American Heart Association recommendations for poststreptococcal reactive arthritis: comment on the article by van Bemmel et al. Arthritis Rheum. 2009;60(11):3516–3518.
• Barash J, Mashiach E, Navon-Elkan P, Berkun Y, Harel L, Tauber T. et al. Differentiation of post-streptococcal reactive arthritis from acute rheumatic fever. J Pediatr. 2008;153(5):696–699.
• Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American 2009;119(11):1541–1551. of Pediatrics Circulation.
• Blyth CC, Robertson PW. Anti-streptococcal antibodies in the diagnosis of acute and poststreptococcal disease: streptokinase versus streptolysin O and deoxyribonuclease B. Pathology. 2006; 38(2): 152-156.
• Jones TD. Diagnosis of rheumatic fever. JAMA. 1944;126:481-484.
• Ferrieri P, for the Jones Criteria Working Group. Proceedings of the Jones criteria workshop. Circulation. 2002;106:2521– 2523.
• Wilson NJ, Voss L, Morreau J, Stewart J, Lennon D. New Zealand guidelines for the diagnosis of acute rheumatic fever: small increase in the incidence of definite cases compared to the American Heart Association Jones criteria. N Z Med J. 2013;126(1379):50-59.
• Ayoub EM, Ahmed S. Update on complications of group A streptococcal infections. Curr Probl Pediatr. 1997;27(3):90– 101.
• Khanna AK, Buskirk DR, Williams RCJ, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest. 1989; 83:1710–1716.
• Harel L, Zeharia A, Kodman Y, Straussberg R, Zabriskie JB, Amir J. Presence of the d8/17 B-cell marker in children with rheumatic fever in Israel. Clin Genet. 2002; 61: 293–298.
• Harel L, Mukamel M, Zeharia A, Kodman Y, Prais D, Uziel Y, et al. Presence of D8/17 B-cell marker in patients with poststreptococcal reactive arthritis. Rheumatol Int. 2007;27(8):695–698.
• Kaplan MH, Meyeserian M. An immunological cross-reaction between group-A streptococcal cells and human heart tissue. Lancet. 1962;279:706–710.
• Kaplan MH, Frengley JD. Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomy and postinfarction syndromes and cardiomyopathies. Am J Cardiol. 1969;24:459–473.
• Hashkes PJ, Tauber T, Someh E, et al. Naproxen as an alternative to Aspirin for the treatment of Arthritis of Rheumatic fever: a randomized trial. J Pediatr. 2003;143(3):399–401.